Abstract
Introduction
Approximately 90 million children less than five years are infected with influenza every year globally. [1] Influenza infection can lead to a range of physiological effects from mild upper respiratory symptoms to critical illness including acute respiratory distress syndrome and septic shock requiring intensive care. [2] The impact of influenza on paediatric intensive care unit (PICU) capacity was demonstrated during the influenza A(H1N1)pdm2009 pandemic in 2009 and 2010, when children were more likely to experience severe morbidity and mortality than during seasonal influenza epidemics. [3, 4] Several multicentre observational studies have highlighted the increased risk of influenza-related PICU admission in children with chronic conditions. [5] [6] [7] [8] [9] Since September 2013, it has been recommended that all children in the UK aged two years and older are vaccinated with influenza vaccine every year under a universal programme which is being progressively rolled out. This replaces a policy of vaccinating only children at high risk of influenza complications due to the presence of chronic illness. The targeted strategy towards high risk groups remains for children aged between six months and two years.
[10] However, influenza vaccination uptake in children in England is low. In 2016/17, the proportion of children vaccinated in England was 19.5% in children between six months and two years and in a high risk group, 34.4% in preschool children, and 53.6% in six to seven year old schoolchildren. [11, 12] Further, there are no licensed vaccines for children aged less than six months old, due to a lack of evidence of effectiveness and concerns about adverse events. [13] Studies have shown that parents' views of influenza as a less serious infection may contribute to low uptake of influenza vaccination in children in the UK. [14, 15] An understanding of risk factors for poor outcome among children admitted to PICU is needed to identify which children benefit most from vaccine protection and therefore motivate higher uptake. A mandatory surveillance scheme was set up by Public Health England in 2011 for reporting the number of laboratory confirmed influenza admissions to higher dependency (HDU) or intensive care units in the UK.
[16] However, information on risk factors, such as underlying chronic conditions, is only reported for a subset of admissions. [17] In this study, we describe characteristics of all children admitted to PICU with influenza in England, and examine risk factors for mortality. We also examine risk factors for two other markers of illness severity: invasive ventilation and treatment with vasoactive drugs, and assess whether mortality and illness severity have changed over time. We use data linkage between PICU and a hospital admission database to improve the detection of influenza cases and reduce under-recording of highrisk chronic conditions.
Materials and methods

Data sources
The Paediatric Intensive Care Audit Network (PICANet)[18] is a national clinical audit that receives demographic and clinical data on all admissions to PICUs in the UK and the Republic of Ireland. Data collection started in England and Wales in 2002. Diagnostic and procedure information is coded in PICANet using Clinical Terms 3 (The Read Codes). Hospital Episode Statistics (HES) is a hospital admission database, comprising all hospital admissions paid for by the National Health Service (NHS) in England.
[19] Diagnoses in HES are recorded using the International Classification of Diseases version 10 (ICD-10). Each child recorded in PICANet was linked to their longitudinal HES admission record (since April 1997) by the HES data providers (NHS Digital) using a deterministic algorithm based on NHS number, date of birth, sex and postcode.
Study population
We extracted data on all influenza-related admissions to PICUs in England for resident children aged less than 16 years between October 2003 and March 2015. An influenza-related admission was defined as a PICU admission in PICANet where either a) any of the diagnostic fields included an influenza-related Read code (see Supplementary Table S1 ), or b) a linked hospital admission starting up to 7 days before or three days after a PICANet admission had an ICD-10 code indicating influenza (J09-J11). Readmissions to PICU within 12 hours of discharge from a previous admission in the same unit were excluded, to allow for children being discharged and readmitted in case of surgery. We defined the winter season as 1 st October in year x to end of March in year x+1.
Outcomes
The primary outcome in this study was mortality during PICU admission. The secondary outcomes were type of ventilation and requirement for vasoactive drugs. Data on these outcomes were recorded in PICANet. Where a child died during a readmission within 12 hours of the previous (index) admission, the mortality outcome was applied to the index admission (and the readmission excluded). Type of ventilation was coded into a three-category variable: no ventilation, non-invasive ventilation (including high-flow nasal oxygen and continuous positive airway pressure) and invasive ventilation (endotracheal intubation or tracheostomy). For the statistical models, we collapsed the no ventilation and non-invasive ventilation categories to derive a binary variable: invasive ventilation and no invasive ventilation. Requirement for vasoactive drugs was coded into a binary variable (yes/no).
Risk factors
We hypothesised, based on previous literature, that age, gender and presence of high-risk conditions would be associated with severe influenza symptoms, including invasive ventilation [7, 20, 21] , and that severe outcomes would vary over time, particularly between pandemic and nonpandemic seasons. We examined whether a child's ethnic group and socio-economic status were also associated with mortality, or need for invasive ventilation and vasoactive drugs.
Age was derived from PICANet records and coded into a four category variable (<6 months, 6-<24 months, 2-<5 years, 5-<16 years), using standard age groups for influenza surveillance, but splitting the youngest age groups according to current eligibility to receive influenza vaccine in the UK. Socio-economic status was estimated using the Index of Multiple Deprivation (IMD),[25] a small area-level (between 1000 and 3000 people) based classification of material deprivation. The IMD score was available from the longitudinal HES record, mapped from the child's residential postcode, and coded into quintiles. We assigned a PICANet admission to the IMD quintile recorded during the hospital episode nearest in time to the PICANet admission date.
We defined the presence of a high-risk chronic condition indicating eligibility to receive influenza vaccination under the targeted programme using a previously published Read code list [26] which has been translated into ICD-10 codes. [27, 28] We searched for the relevant Read codes during the PICANet admission or for the corresponding ICD-10 codes during the child's longitudinal HES records at any time before PICANet admission. The conditions were classified into six groups to ensure sufficient numbers for analysis: neurological, respiratory, cardiovascular conditions, immunodeficiency, kidney conditions or diabetes, and liver conditions or obesity. For the statistical models, we used a binary indicator: presence of a high-risk condition: yes/no.
We defined five time periods to examine changes over time in the probability of each outcome: 
Statistical analyses
We estimated the number of admissions and influenza-related PICU admission rates during winter seasons per 100,000 children by sex and age group. Denominators were derived from mid-year population estimates from the Office for National Statistics.
[29] We combined admissions for children under two years of age since denominator populations for children aged <6 months were not available.
We determined the proportion of admitted children with a high-risk condition, and the proportion of deaths in PICU where the child had a high-risk condition. To examine risk factors for mortality during PICU admission, we fitted mixed effects logistic regression models with death as the outcome variable, and unit as the random effect. We included unit as a random effect since outcomes within units have been shown to be more similar than across units [30, 31] , due to differences in the casemix of children admitted, as well as differences in care practices. Age group, gender, presence of high-risk conditions and time period were included in the baseline model a priori. We added ethnic group and IMD quintile in a forward stepwise fashion. Model fit was compared using the Akaike Information Criterion (AIC). Admissions with missing values for any of the outcomes or risk factors were excluded. We repeated the modelling process for the outcomes ventilation type and requirement for vasoactive drugs.
Ethical approval
Collection of personally identifiable data has been approved by the 
Results
We identified 1961 influenza-related PICU admissions in 1778 children to 31 PICUs. 1628 children had one influenza-related PICU admission (91.6%), 123 children (6.9%) had two and 27 children had three or more (1.5%). Of the 183 readmissions, 171 (93.4%) occurred within six months of the first admission.
Of the 1961 admissions, 20.7% (406 admissions) were identified as influenza-related admissions from PICANet only, 52.8% (1035 admissions) from hospital admission records only, and 26.5% (520 admissions) could be identified from both data sources. Of the 926 admissions identified from PICU records, 95.8% (887 admissions) were linked to at least one preceding hospital record. 26% of influenza-related PICU admissions were in infants aged less than six months old (Table 1) , and 56% were in children less than two years old.
1540 admissions were in children with at least one high-risk condition (78.5%); and 63.5% of these were among children with high-risk conditions from more than one of the six groups of conditions (978 admissions). Respiratory and neurological conditions were the most common types of high-risk conditions among admitted children. The proportion of children with high-risk conditions increased with age. Among children aged six months to less than two years old, 452 of 589 admissions were in children with high-risk conditions (76.7%), increasing to 473 of 514 admissions (92.2) in children aged 5-15 years.
The crude admission rate was 2.6/100,000 children during winter seasons (95% CI 2.4, 2.7). Boys had significantly higher admission rates than girls: 2.9 (2.7, 3.1) versus 2.3 (2.1, 2.4). Age-specific rates were 10.5 (9.8, 11.3) among <2 year olds, 2.6 (2.3, 2.9) among 2-<5 year olds and 1.0 (0.9, 1.1) among 5-<16 year olds. In the four seasons since the end of the influenza pandemic, 138 children were admitted to PICU with influenza on average each season. 
Risk factors for mortality (primary outcome)
Overall, 143 admissions ended in death (7.3%). Only 3.5% of all deaths (n=5) were in children without high-risk conditions; these were not concentrated in any year or in any age group. The odds of mortality was over nine times higher for children with high-risk conditions (Table 2) . Girls, and children from Asian/Asian British or other non-majority ethnic groups, apart from black/black British also experienced significantly higher odds of dying during admission. The odds of mortality was significantly increased before and during the pandemic compared to the post-pandemic period. (Table 3) . The presence of a high-risk condition was not significantly associated with the odds of invasive ventilation. The probability of invasive ventilation was significantly decreased during the first wave of the pandemic, and during the period since September 2013 compared to the immediate post-pandemic period. Table S3, Table 4 ). Girls were significantly more likely than boys to be given vasoactive drugs, even after adjustment for age and high-risk conditions. Compared to the postpandemic period, use of vasoactive drugs was significantly lower during the period after the introduction of universal influenza vaccination. 
Discussion
There are around 140 influenza-related PICU admissions every year in England. Over three quarters of children with an influenza diagnosis admitted to PICU had high-risk conditions and a quarter of admissions occurred in children aged less than six months old who are too young to be vaccinated. Children admitted to PICU with influenza were more likely to be boys; and boys were significantly more likely to survive. Older children, and children from an Asian or other ethnic group also had significantly higher odds of mortality even after adjustment for high-risk conditions. This is the largest UK study to date of severe influenza infections in children resulting in PICU admission. Linkage between PICU and the national hospital admission database improved the ascertainment of high-risk conditions: the proportion of admitted children with high-risk conditions was over 50% higher when using data from linked longitudinal hospital records compared to using intensive care data alone. This underrecording arises since some PICUs tend to report the main reason for admission to PICU only. Linkage between PICU and hospital admission data also allowed more influenza-related PICU admissions to be identified, thus avoiding the low sensitivity of diagnostic coding for specific respiratory infections. [32] National data collection over several years was required to estimate relative odds of mortality according to key risk factors, since influenzarelated deaths in children are rare.
Our study also had some weaknesses. First, we did not have access to data on laboratory confirmation of influenza infection. There is no national testing protocol for children presenting to hospital with symptoms of respiratory infections in England. However, we note that the average number of PICU admissions in children aged 0-14 years in this study between weeks 40 and 12 in the 2013/14 and 2014/15 influenza seasons is similar to the number published by Public Health England through the USISS surveillance scheme which only includes laboratory confirmed influenza (although the USISS scheme also covers higher dependency units). [33, 34] Second, influenza vaccination history is not recorded on PICANet nor HES, and there is currently no national immunisation database anywhere in the UK which captures influenza vaccination in children. We could therefore not estimate the proportion of children admitted to PICU with influenza who had been vaccinated. Similarly, data on antiviral use was not available in PICANet, nor in HES.
Third, we used an extract of linked hospital admission records for children who had had at least one PICU admission. Therefore, we could not estimate the proportion of children admitted to hospital with influenza who were admitted to PICU. Linkage between PICANet and a whole-nation birth cohort created using longitudinal HES data for all children born in England [35] could be used to examine the impact of the introduction of the universal paediatric influenza vaccination policy on children with specific high-risk conditions.
Children with high-risk conditions accounted for over 75% of influenza-related PICU admissions, and 83.5% among admissions in children aged over six months old. These children also accounted for 97% of the deaths. A previous UK study conducted during the 2009 pandemic based on death certification data and clinician reports found that two thirds of deaths were in children with high-risk conditions. [21] In contrast, a study of PICU admissions in Australia and New Zealand 2007-2013 found that 59% of admissions were in previously healthy children. [36] . However this study was based on PICU reports only and high-risk conditions may have been under-recorded, emphasising the value of linking intensive care audit to hospital admission data. Influenza vaccination has been found to reduce the risk of PICU admission in an observational case-negative control study conducted in the United States. [37] Influenza vaccine uptake in England among children with high-risk conditions has remained below 30% for children aged 6 months to less than two years, and below 50% for children aged 2-15 years since 2009/10. The low uptake has been linked to concerns about vaccine safety and parental views of influenza as a less serious illness, as well as difficulties accessing vaccination services. [14] Increasing the burden of influenza on PICUs should therefore focus on increasing vaccination uptake among children with high-risk chronic conditions, particularly among children aged between six months and two years who have the lowest uptake, and higher PICU admission rates than older children. Children aged less than six months accounted for 26% of PICU admissions. Since there are no influenza vaccines licensed for this age group, alternative strategies including maternal vaccination during pregnancy, [38] and sibling vaccination [28] are likely to reduce the burden of influenza among this age group.
Children from an Asian/Asian British or other non-majority ethnic background were more likely to be admitted to PICU with an influenza-related infection and more likely to die after admission. The increased odds of mortality remained, even after adjusting for the presence of high-risk conditions. Previous studies have also identified an increased risk of death in children from an Asian ethnic group following PICU admission. [39, 40] The type and severity of comorbidities could be different in children from non-majority ethnic groups. A study using a national birth cohort of children with specific high-risk conditions linked to PICANet data is required to determine if this is the case.
Further, we found that girls were significantly more likely than boys to die after admission, despite higher PICU admission rates in boys. Girls were also more likely to require vasoactive drugs, but less likely to require invasive ventilation. A higher mortality rate in girls was also found among children admitted to PICUs in the United States during the pandemic 2009/10 season, [41] and among all PICANet admissions, [31] although the increased odds of mortality for girls among all PICANet admissions was significantly lower than in this study. Other case series of childhood influenza deaths (irrespective of PICU admission) have had a more even sex distrbution. [21, 42] A whole-country birth cohort linked to PICANet and a national hospital admission database would be required to determine whether the increased mortality rate in girls could be explained by a higher proportion of boys dying before PICU admission.
Mortality among admitted children was significantly higher before and during the H1N1 pandemic compared to the four seasons following the pandemic, even after adjustment for age and the presence of high-risk conditions. Higher mortality rates for pandemic, compared to seasonal, influenza in children were also reported in Argentina in 2009/10. [43] In contrast, a multi-centre study in Canada reported no significant difference between mortality rates among children hospitalised during pre-pandemic and pandemic influenza periods. [44] Overall mortality in PICUs in the UK and Ireland have decreased since 2003 when PICANet data collection began.
[30] The decreased mortality observed in the seasons since 2009/10 in our study may also be explained by variation over time in case detection and the recording of underlying high-risk conditions. We found a significantly decreased risk of invasive ventilation during the first two waves of the pandemic and in the last two seasons of the study (2013/14 and 2014/15) compared to the two immediate postpandemic winters (2011/12 and 2012/13). Therefore, admission thresholds may also have varied across the study period. Follow-up studies are required to determine whether the decline in mortality among children with influenza in PICU observed since the end of the pandemic is maintained over subsequent seasons.
Conclusions
Infants and children with high-risk conditions account for three quarters of influenza-associated admissions to PICU Increasing influenza vaccination uptake among children with high-risk conditions is therefore needed to decrease the influenza burden on PICUs. Further research, based on linkage between PICANet records and a national birth cohort of children created using administrative databases, is required to explain mortality differences among admitted children according to sex and ethnic group. HQIP is led by a consortium of the Academy of Medical Royal Colleges, the Royal College of Nursing, and National Voices. Its aim is to promote quality improvement, and in particular to increase the impact that clinical audit has on healthcare quality in England and Wales. HQIP holds the contract to commission, manage and develop the NCAPOP, comprising more than 30 clinical audits and clinical outcome review programmes that cover care provided to people with a wide range of medical, surgical, and mental health conditions. The programme is funded by NHS England, the Welsh Government and, with some individual audits, also funded by the Health Department of the Scottish government, the Northern Ireland Department of Health, the States of Jersey, Guernsey, and the Isle of Man. The PICANet Audit is also funded by NHS Wales, NHS Lothian/National Service Division NHS Scotland, the Royal Belfast Hospital for Sick Children, The National Office of Clinical Audit (NOCA) of the Republic of Ireland, and HCA Healthcare.
Financial support
The funders had no role in any of the following: study design; collection, analysis and interpretation of data; in the writing of the report; and the decision to submit the article for publication.
Declaration of interests
PH reports receiving a travel award from the European Society for Paediatric Infectious Diseases (ESPID), supported by GSK, to present results related to this work at the annual ESPID conference in 2016. No other authors report a conflict of interest.
Highlights
 79% of influenza-related PICU admissions were in children with high-risk chronic conditions  7.3% of admissions ended in death for the admitted child  Girls admitted to PICU with influenza had almost twice the odds of dying compared to boys  Mortality as significantly higher before and during the A(H1N1)pdm 2009 pandemic compared to the post-pandemic period 
